UAE- Cebu Pacific releases travel advisory on extension of entry restrictions for foreign nationals from January 16 to 31, 2021


(MENAFN- Dubai PR Network) Dubai, UAE, January 16, 2021:  Due to the new COVID-19 variant, the Philippine government has extended the temporary ban for foreign nationals until January 31, 2021. During this period, only Filipino citizens will be accepted on flights from Dubai, Hong Kong, Nagoya (Japan), Singapore, and Seoul (South Korea). 

Cebu Pacific (CEB) will not accept foreign nationals who originated from, transited via, or visited within 14 days prior to arrival in the Philippines, any of the 34 countries specified by the Inter-Agency Task Force (IATF). The list of affected countries and complete details may be viewed here: http://bit.ly/IATFResoNo94_011521   

 

•    Free rebooking within 90 days waived rebooking fee and fare difference  
•    Full travel fund, valid for two (2) years  
•    Full refund  

In compliance with IATF regulations, Filipinos who wish to proceed with their travel plans will be subjected to a mandatory 14-day quarantine at an accredited facility upon arrival in Manila. 
 
CEB will continue to operate its domestic and international flights as scheduled. Before going to the airport, passengers are advised to check the real-time status of flights on our website: bit.ly/CEBFlightStatusCheck  
 
A complete list of operational flights, along with travel requirements, safety protocols, and frequently asked questions (FAQs) may be viewed here: bit.ly/CEBFlightReminders  
 
We continue to work closely with the authorities and will provide updates through our website and official social media accounts as necessary.   


MENAFN16012021003092003082ID1101440638


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.